October 7, 2024

Wound Care Market Size Will be USD 35.33 Billion By 2032

The global wound care market size reached USD 23.57 billion in 2023 and is expected to be worth around USD 35.33 billion by 2032, growing a CAGR of 4.40% from 2023 to 2032.

Wound Care Market Size 2023 To 2032

Key Takeaways

  • North America contributed more than 46% of revenue share in 2022.
  • Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By application, the chronic segment has held the largest market share of 75% in 2022.
  • By application, the acute segment is anticipated to grow at a remarkable CAGR of 5.1% between 2023 and 2032.
  • By end-use, the hospital segment generated over 39% of revenue share in 2022.
  • By end-use, the home care segment is expected to expand at the fastest CAGR over the projected period.
  • By product, the advanced wound dressing segment generated over 34% of revenue share in 2022.
  • By product, the surgical wound care segment is expected to expand at the fastest CAGR over the projected period.
  • By mode of purchase, the prescribed segment generated over 65% of revenue share in 2022.
  • By mode of purchase, the non-prescribed (OTC) segment is expected to expand at the fastest CAGR over the projected period.

The global Wound Care Market has witnessed significant growth in recent years, driven by an increasing aging population, rising incidences of chronic wounds, and advancements in wound care technologies. This market encompasses a wide array of products and services designed to promote healing and prevent infection in wounds of varying complexities.

Wound care is a critical component of healthcare, addressing a spectrum of injuries, from minor cuts and abrasions to complex surgical wounds. The market is comprised of various products, including dressings, bandages, topical agents, and devices, catering to both acute and chronic wound management.

Get a Sample: https://www.precedenceresearch.com/sample/3616

Growth Factors:

  • Aging Population and Chronic Diseases: The aging demographic worldwide has led to a higher prevalence of chronic diseases, contributing to an increased demand for advanced wound care solutions. Conditions like diabetes and vascular diseases often result in chronic wounds, necessitating sophisticated wound care interventions.
  • Technological Advancements: The constant evolution of wound care technologies has played a pivotal role in market growth. Innovations such as smart dressings, bioactive materials, and advanced therapies accelerate the healing process and improve patient outcomes. These technological advancements have enhanced the efficacy and efficiency of wound care treatments.
  • Rising Awareness and Education: Growing awareness about the importance of proper wound care and the availability of diverse treatment options have encouraged individuals to seek timely interventions. Healthcare professionals and organizations are also focusing on educating both patients and caregivers, fostering a proactive approach towards wound management.
  • Increasing Surgical Procedures: The global rise in surgical procedures, driven by advancements in medical science and increasing healthcare accessibility, has positively impacted the wound care market. Post-surgical wound management is a crucial aspect of patient recovery, driving the demand for specialized wound care products and services.
  • Government Initiatives and Healthcare Infrastructure: Supportive government initiatives aimed at improving healthcare infrastructure and accessibility to wound care facilities have contributed to market growth. Investments in research and development, coupled with regulatory measures, ensure the quality and safety of wound care products, fostering market expansion.

Wound Care Market Scope

Report Coverage Details
Market Size in 2023 USD 23.57 Billion
Market Size by 2032 USD 35.33 Billion
Growth Rate from 2023 to 2032 CAGR of 4.40%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Application, By End-use, By Product, and By Mode of Purchase
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Blood Culture Test Market Size To Attain USD 16.31 Bn By 2032

By Application:

Wound care products cater to a diverse range of medical needs, and their applications span various medical conditions. One significant segment is acute wounds, including surgical wounds and traumatic injuries. These wounds often require specialized products for efficient healing and prevention of infections. Another key application is chronic wounds, which can result from conditions like diabetic ulcers, pressure ulcers, or venous leg ulcers. The demand for wound care products in addressing chronic wounds is steadily growing due to the rising incidence of diabetes and an aging population.

By End-use:

The end-use segmentation of the wound care market encompasses various healthcare settings where these products are utilized. Hospitals and clinics represent major end-users, as they handle a broad spectrum of wounds, both acute and chronic. Home healthcare settings have also become a significant end-use segment, driven by the increasing trend of managing certain wounds outside traditional medical facilities. Additionally, wound care products find application in long-term care facilities, where the focus is on managing chronic wounds associated with aging and underlying health conditions.

By Product:

Wound care products come in a diverse range, addressing specific needs at different stages of wound healing. Advanced wound care products, such as hydrocolloids, alginates, and hydrogels, are gaining prominence for their effectiveness in promoting faster healing and reducing infection risks. Traditional wound care products like dressings and bandages remain essential, providing basic protection and support for various wounds. Additionally, active wound care products, including growth factors and biological dressings, are emerging as innovative solutions for promoting tissue regeneration and accelerating the healing process.

By Mode of Purchase:

The mode of purchase in the wound care market involves both traditional procurement channels and modern avenues. Hospitals and healthcare institutions often procure wound care products through direct contracts with manufacturers or distributors. Retail pharmacies play a crucial role in providing over-the-counter wound care products to consumers for self-management of minor wounds. With the advent of e-commerce, online platforms have become increasingly popular for purchasing wound care products, offering convenience and a wide range of options. This shift in the mode of purchase reflects evolving consumer preferences and the influence of digital platforms in the healthcare industry.

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Wound Care Market Players

  • 3M Company
  • Smith & Nephew plc
  • Johnson & Johnson
  • Mölnlycke Health Care
  • Coloplast A/S
  • ConvaTec Group plc
  • B. Braun Melsungen AG
  • Medtronic plc
  • Acelity L.P. Inc.
  • Integra LifeSciences Corporation
  • Ethicon, Inc. (a subsidiary of Johnson & Johnson)
  • Derma Sciences, Inc. (acquired by Integra LifeSciences)
  • Misonix, Inc.
  • Organogenesis Holdings Inc.
  • Hollister Incorporated

Segments Covered in the Report

By Application

  • Chronic
  • Acute

By End-use

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Physician’s Office
  • Nursing Homes
  • Others

By Product

  • Advanced Wound Dressing
  • Surgical Wound Care
  • Traditional Wound Care
  • Wound Therapy Devices

By Mode of Purchase

  • Prescribed
  • Non-prescribed (OTC)

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Wound Care Market 

5.1. COVID-19 Landscape: Wound Care Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Wound Care Market, By Application

8.1. Wound Care Market, by Application, 2023-2032

8.1.1. Chronic

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Acute

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Wound Care Market, By End-use

9.1. Wound Care Market, by End-use, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Specialty Clinics

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Home Healthcare

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Physician’s Office

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Nursing Homes

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Wound Care Market, By Product 

10.1. Wound Care Market, by Product, 2023-2032

10.1.1. Advanced Wound Dressing

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Surgical Wound Care

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Traditional Wound Care

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Wound Therapy Devices

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Wound Care Market, By Mode of Purchase 

11.1. Wound Care Market, by Mode of Purchase, 2023-2032

11.1.1. Prescribed

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Non-prescribed (OTC)

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Wound Care Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.2. Market Revenue and Forecast, by End-use (2020-2032)

12.1.3. Market Revenue and Forecast, by Product (2020-2032)

12.1.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

Chapter 13. Company Profiles

13.1. 3M Company

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Smith & Nephew plc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Johnson & Johnson

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Mölnlycke Health Care

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Coloplast A/S

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. ConvaTec Group plc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. B. Braun Melsungen AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Medtronic plc

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Acelity L.P. Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Integra LifeSciences Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/


Leave a Reply

Your email address will not be published. Required fields are marked *